Lydia Woelflingseder
3PUBLICATIONS
44CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|Sep 09, 2024
Zongertinib (BI 1810631), an Irreversible HER2 TKI, Spares EGFR Signaling and Improves Therapeutic Response in Preclinical Models and Patients with HER2-Driven Cancers.Birgit Wilding, Lydia Woelflingseder, Anke Baum
|Feb 08, 2024
Discovery of a Novel Potent EGFR Inhibitor Against EGFR Activating Mutations and On-Target Resistance in NSCLC.Eun Ji Lee, Seung Yeon Oh, You Won Lee
|Apr 23, 2021
Exploring the dermotoxicity of the mycotoxin deoxynivalenol: combined morphologic and proteomic profiling of human epidermal cells reveals alteration of lipid biosynthesis machinery and membrane structural integrity relevant for skin barrier function.Giorgia Del Favero, Lukas Janker, Benjamin Neuditschko
Pageof 1
Frequent Collaborators
2 joint publications
Flavio Solca
2 joint publications
Anke Baum
1 joint publications
Giorgia Del Favero
1 joint publications
Lukas Janker
1 joint publications
Benjamin Neuditschko
1 joint publications
Julia Hohenbichler
1 joint publications
Christopher Gerner
1 joint publications
Doris Marko
1 joint publications
Ralph A Neumüller
1 joint publications
Seung Yeon Oh
